Home LiteratureArticle Details
PMID: 16002755 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Review

Custom design of the cardiac microenvironment with biomaterials.

Circulation research ·Vol. 97 ·No. 1 ·2005-07-08 ·Pages 8-15

Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT

Abstract

Many strategies for repairing injured myocardium are under active investigation, with some early encouraging results. These strategies include cell therapies, despite little evidence of long-term survival of exogenous cells, and gene or protein therapies, often with incomplete control of locally-delivered dose of the factor. We propose that, ultimately, successful repair and regeneration strategies will require quantitative control of the myocardial microenvironment. This precision control can be engineered through designed biomaterials that provide quantitative adhesion, growth, or migration signals. Quantitative timed release of factors can be regulated by chemical design to direct cellular differentiation pathways such as angiogenesis and vascular maturation. Smart biomaterials respond to the local environment, such as protease activity or mechanical forces, with controlled release or activation. Most of these new biomaterials provide much greater flexibility for regenerating tissues ex vivo, but emerging technologies like self-assembling nanofibers can now establish intramyocardial cellular microenvironments by injection. This may allow percutaneous cardiac regeneration and repair approaches, or injectable-tissue engineering. Finally, materials can be made to multifunction by providing sequential signals with custom design of differential release kinetics for individual factors. Thus, new rationally-designed biomaterials no longer simply coexist with tissues, but can provide precision bioactive control of the microenvironment that may be required for cardiac regeneration and repair.

MeSH Terms
Angiogenesis Inducing Agents/metabolism Animals Biocompatible Materials Biodegradation, Environmental Cell Adhesion Gene Transfer, Horizontal Heart Diseases/therapy Humans Injections Matrix Metalloproteinases/metabolism Proteins/metabolism Regeneration Tissue Engineering/methods
Chemicals
Angiogenesis Inducing Agents Biocompatible Materials Proteins Matrix Metalloproteinases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Davis Michael E
Cardiovascular Division , Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Hsieh Patrick C H
Grodzinsky Alan J
Lee Richard T
References (62)
62 references, click to expand
  1. In situ immobilization of proteins and RGD peptide on polyurethane surfaces via poly(ethylene oxide) coupling polymers for human endothelial cell growth.
    Biomacromolecules. 2002 Nov-Dec;3(6):1286-95 PMID: 12425667
  2. Self-assembling short oligopeptides and the promotion of angiogenesis.
    Biomaterials. 2005 Aug;26(23):4837-46 PMID: 15763263
  3. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation.
    J Clin Invest. 2004 Sep;114(6):775-83 PMID: 15372101
  4. Materials science. Smart biomaterials.
    Science. 2004 Sep 24;305(5692):1923-4 PMID: 15448260
  5. Functional heterogeneity of oxygen supply-consumption ratio in the heart.
    Cardiovasc Res. 1999 Dec;44(3):488-97 PMID: 10690280
  6. Novel heparin/alginate gel combined with basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve.
    J Biomed Mater Res A. 2004 Dec 15;71(4):661-8 PMID: 15505831
  7. Nanoscale Adhesion Ligand Organization Regulates Osteoblast Proliferation and Differentiation.
    Nano Lett. 2004 Jul 13;4(8):1501-1506 PMID: 25067913
  8. GRGDSP peptide-bound silicone membranes withstand mechanical flexing in vitro and display enhanced fibroblast adhesion.
    Biomaterials. 2002 Aug;23(15):3159-68 PMID: 12102187
  9. Tissue engineered bone: measurement of nutrient transport in three-dimensional matrices.
    J Biomed Mater Res A. 2003 Oct 1;67(1):357-67 PMID: 14517896
  10. Preparation and characterization of a highly macroporous biodegradable composite tissue engineering scaffold.
    J Biomed Mater Res A. 2004 Dec 1;71(3):480-7 PMID: 15478140
  11. Fabrication of novel biomaterials through molecular self-assembly.
    Nat Biotechnol. 2003 Oct;21(10):1171-8 PMID: 14520402
  12. Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds.
    Differentiation. 2003 Jun;71(4-5):262-70 PMID: 12823227
  13. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells.
    Circulation. 2005 Feb 1;111(4):442-50 PMID: 15687132
  14. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.
    J Cell Biol. 2003 Jun 23;161(6):1163-77 PMID: 12810700
  15. Diffusion in musculoskeletal tissue engineering scaffolds: design issues related to porosity, permeability, architecture, and nutrient mixing.
    Ann Biomed Eng. 2004 Dec;32(12):1728-43 PMID: 15675684
  16. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model.
    Heart Vessels. 2003 May;18(2):93-9 PMID: 12756606
  17. Hyaluronan microspheres for sustained gene delivery and site-specific targeting.
    Biomaterials. 2004 Jan;25(1):147-57 PMID: 14580918
  18. Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation.
    J Vasc Surg. 2005 Jan;41(1):82-90 PMID: 15696049
  19. Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration.
    Circulation. 2004 Aug 24;110(8):962-8 PMID: 15302801
  20. Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer.
    Biomaterials. 2005 Apr;26(10):1139-44 PMID: 15451633
  21. Therapeutic myocardial angiogenesis with vascular endothelial growth factors.
    Mol Cell Biochem. 2004 Sep;264(1-2):63-74 PMID: 15544036
  22. Enhancing the biological activity of immobilized osteopontin using a type-1 collagen affinity coating.
    J Biomed Mater Res A. 2004 Jul 1;70(1):10-9 PMID: 15174104
  23. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization.
    FASEB J. 2004 May;18(7):851-3 PMID: 15001565
  24. Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution.
    Biomacromolecules. 2004 Sep-Oct;5(5):1720-7 PMID: 15360280
  25. Myocyte and myogenic stem cell transplantation in the heart.
    Cardiovasc Res. 2003 May 1;58(2):336-50 PMID: 12757868
  26. Selective differentiation of neural progenitor cells by high-epitope density nanofibers.
    Science. 2004 Feb 27;303(5662):1352-5 PMID: 14739465
  27. A novel biotinylated degradable polymer for cell-interactive applications.
    Biotechnol Bioeng. 1998 Jun 5;58(5):529-35 PMID: 10099289
  28. Interactions of 3T3 fibroblasts and endothelial cells with defined pore features.
    J Biomed Mater Res. 2002 Aug;61(2):212-7 PMID: 12007201
  29. Construction of varying porous structures in acellular bovine pericardia as a tissue-engineering extracellular matrix.
    Biomaterials. 2005 May;26(14):1905-13 PMID: 15576164
  30. Biomaterials: where we have been and where we are going.
    Annu Rev Biomed Eng. 2004;6:41-75 PMID: 15255762
  31. ECM and cell surface proteolysis: regulating cellular ecology.
    Cell. 1997 Nov 14;91(4):439-42 PMID: 9390552
  32. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone.
    Endocrinology. 2001 Mar;142(3):1325-32 PMID: 11181551
  33. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis.
    Genes Dev. 2002 Oct 15;16(20):2684-98 PMID: 12381667
  34. New directions in strategies using cell therapy for heart disease.
    J Mol Med (Berl). 2003 May;81(5):288-96 PMID: 12698252
  35. Synthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IX.
    Bioconjug Chem. 2004 Jul-Aug;15(4):931-41 PMID: 15264885
  36. Smart and biofunctional streptavidin.
    Biomol Eng. 1999 Dec 31;16(1-4):93-9 PMID: 10796990
  37. Injectable cartilage tissue engineering.
    Expert Opin Biol Ther. 2004 Dec;4(12):1849-59 PMID: 15571448
  38. Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells.
    Science. 2004 Oct 8;306(5694):247-52 PMID: 15472070
  39. Modeling advection and diffusion of oxygen in complex vascular networks.
    Ann Biomed Eng. 2001 Apr;29(4):298-310 PMID: 11339327
  40. Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: implications for cartilage tissue repair.
    Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9996-10001 PMID: 12119393
  41. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
    Drug Deliv. 2001 Oct-Dec;8(4):215-22 PMID: 11757779
  42. Polymeric growth factor delivery strategies for tissue engineering.
    Pharm Res. 2003 Aug;20(8):1103-12 PMID: 12948005
  43. Bioinspired pH-responsive polymers for the intracellular delivery of biomolecular drugs.
    Bioconjug Chem. 2003 Mar-Apr;14(2):412-9 PMID: 12643752
  44. Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks.
    Biomacromolecules. 2005 Jan-Feb;6(1):386-91 PMID: 15638543
  45. Synthesis and characterisation of a degradable poly(lactic acid)-poly(ethylene glycol) copolymer with biotinylated end groups.
    Biomacromolecules. 2001 Summer;2(2):575-80 PMID: 11749223
  46. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants.
    Biomaterials. 2004 Jun;25(14):2789-98 PMID: 14962557
  47. Controlled degradation of hydrogels using multi-functional cross-linking molecules.
    Biomaterials. 2004 Jun;25(13):2461-6 PMID: 14751730
  48. Affinity regulates spatial range of EGF receptor autocrine ligand binding.
    Dev Biol. 2002 Oct 15;250(2):305-16 PMID: 12376105
  49. Cells, scaffolds, and molecules for myocardial tissue engineering.
    Pharmacol Ther. 2005 Feb;105(2):151-63 PMID: 15670624
  50. Polymeric system for dual growth factor delivery.
    Nat Biotechnol. 2001 Nov;19(11):1029-34 PMID: 11689847
  51. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2.
    Nat Med. 2003 May;9(5):604-13 PMID: 12669032
  52. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.
    J Clin Invest. 2004 Feb;113(4):516-27 PMID: 14966561
  53. Engineered heart tissue for regeneration of diseased hearts.
    Biomaterials. 2004 Apr;25(9):1639-47 PMID: 14697865
  54. Synthetic extracellular matrices for tissue engineering and regeneration.
    Curr Top Dev Biol. 2004;64:181-205 PMID: 15563948
  55. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial.
    Circulation. 1999 Nov 2;100(18):1865-71 PMID: 10545430
  56. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices.
    Nat Biotechnol. 2003 May;21(5):513-8 PMID: 12704396
  57. Collagenous matrices as release carriers of exogenous growth factors.
    Biomaterials. 2004 Aug;25(18):4513-20 PMID: 15046942
  58. Modulating angiogenesis: more vs less.
    JAMA. 2004 Aug 25;292(8):972-7 PMID: 15328330
  59. Critical role of microenvironmental factors in angiogenesis.
    Curr Atheroscler Rep. 2005 May;7(3):227-34 PMID: 15811258
  60. Controlled growth factor release from synthetic extracellular matrices.
    Nature. 2000 Dec 21-28;408(6815):998-1000 PMID: 11140690
  61. Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells.
    Circ Res. 1999 Dec 3-17;85(12):1118-23 PMID: 10590237
  62. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall.
    Genes Dev. 2003 Aug 1;17(15):1835-40 PMID: 12897053
Article Info
Journal
Circulation research
Abbr.
Circ Res
ISSN
1524-4571
Published
2005-07-08
Pages
8-15
Language
English
Region
United States
NLM ID
0047103
PMCID
PMC2754580
Subset
IM
Grants
NHLBI NIH HHS · F32 HL073574 · United States
NHLBI NIH HHS · F32 HL073574-03 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]